# US 2006/0154872 A1 · Hemiasterlin derivatives and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154872 A1
- Document ID: US20060154872A1
- Status: Published application
- Kind: A1
- Application number: 11/340,256
- Filed: 2006-01-26
- Published: 2006-07-13
- Earliest claimed: 2002-03-22
- Assignees: Eisai Co., Ltd.
- Inventors: Silvio Campagna; Francis Fang; James Kowalczyk; Shawn Schiller; Boris Seletsky; Mark Spyvee; Hu Yang
- Web page: https://patentgrep.com/patent/US20060154872A1

## CPC

- C07D 207/04: having no double bonds between ring members or between ring members and non-ring members
- A61P 35/00: Antineoplastic agents
- C07D 207/12: Oxygen or sulfur atoms
- C07D 207/16: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 207/42: Nitro radicals
- C07D 209/20: substituted additionally by nitrogen atoms, e.g. tryptophane
- C07D 211/60: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 217/26: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 223/06: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms (halogen atoms C07D223/04)
- C07D 233/84: Sulfur atoms
- C07D 237/04: having less than three double bonds between ring members or between ring members and non-ring members
- C07D 241/04: having no double bonds between ring members or between ring members and non-ring members
- C07D 265/30: not condensed with other rings
- C07D 277/06: with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 279/12: not condensed with other rings
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 403/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 471/04: Ortho-condensed systems
- C07K 5/0205: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
- C07K 5/0207: {containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids}
- C07K 5/0821: {with the first amino acid being heterocyclic, e.g. His, Pro, Trp}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.

## Claims

### Claim at position 1

1-55. (canceled)

### Claim 56

An intermediate having the structure:
wherein g is 1, 2, 3 or 4;
L is CRL1RL2, wherein each occurrence of RL1, RL2 and RL3 is independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
each occurrence of RG1, RM1 and RM2 is each independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
wherein any two adjacent RL1, RL2, RL3, RG1, RM1 or RM2 groups, taken together, form a substituted or unsubstituted alicyclic or heteroalicyclic moiety containing 3-6 atoms or an aryl or heteroaryl moiety;
R2 is hydrogen, —(C═O)Rc or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein each occurrence of RC is independently hydrogen, OH, ORD, or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein RD is an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
R6 is hydrogen, —(C═O)RE or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety, wherein each occurrence of RE is independently hydrogen, OH, ORF, or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein RF is an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
wherein at least one of R2, R6, RG1, RM1 and RM2 is not hydrogen or an aliphatic, alicyclic or aryl moiety.

### Claim 57 (depends on 56)

The intermediate of claim 56 having the structure:

### Claim 58

An intermediate having the structure:
wherein Rx1 and Rx2 are independently hydrogen, aliphatic, alicyclic or aryl;
g is 1, 2, 3 or 4;
L is CRL1RL2, wherein each occurrence of RL1, RL2 and RL3 is independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
each occurrence of RG1, RM1 and RM2 is each independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
wherein any two adjacent RL1, RL2, RL3, RG1, RM1 or RM2 groups, taken together, form a substituted or unsubstituted alicyclic or heteroalicyclic moiety containing 3-6 atoms or an aryl or heteroaryl moiety;
R2 is hydrogen, —(C═O)RC or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein each occurrence of RC is independently hydrogen, OH, ORD, or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein RD is an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
R6 is hydrogen, —(C═O)RE or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety, wherein each occurrence of RE is independently hydrogen, OH, ORF, or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein RF is an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
wherein at least one of R2, R6, RG1, Rx1, Rx2, RM1 and RM2 is not hydrogen or an aliphatic, alicyclic or aryl moiety.

### Claim 59 (depends on 58)

The intermediate of claim 58 having the structure:

### Claim 60 (depends on 58, 59)

The intermediate of claim 58 or 59 wherein Rx1 and Rx2 are independently hydrogen, alkyl or aryl.

### Claim 61 (depends on 58, 59)

The intermediate of claim 58 or 59 wherein Rx1 and Rx2 are each hydrogen.

### Claim 62 (depends on 56, 57, 58, 59)

The intermediate of any one of claims 56-59 wherein R2 is hydrogen, or a substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl, heteroalkyl, -alkyl(aryl) or acyl moiety.

### Claim 63 (depends on 62)

The intermediate of claim 62 wherein R2 is methyl, ethyl, propyl, butyl, pentyl, tert-butyl, i-propyl, —CH(CH3)Et, —CH(CH3)CH2CH2CH3, —CH(CH3)CH2CH2CH2CH3, —CH2CH(CH3)2, —CH(CH3)CH(CH3)2, —C(CH3)2Et, —CH(CH3)cyclobutyl, —CH(Et)2, —C(CH3)2C≡CH, cyclohexyl, cyclopentyl, cyclobutyl or cyclopropyl.

### Claim 64 (depends on 62)

The intermediate of claim 62 wherein R2 is methyl, ethyl, propyl or i-propyl.

### Claim 65 (depends on 56, 57, 58, 59)

The intermediate of any one of claims 56-59 wherein R6 is methyl, ethyl, propyl, butyl, pentyl, tert-butyl, i-propyl, —CH(CH3)CH2CH3, —CH2CH(CH3)2, cyclohexyl, cyclopentyl, cyclobutyl or cyclopropyl; and R2 is methyl, ethyl, propyl, butyl, pentyl, tert-butyl, i-propyl, —CH(CH3)Et, —CH(CH3)CH2CH2CH3, —CH(CH3)CH2CH2CH2CH3, —CH2CH(CH3)2, —CH(CH3)CH(CH3)2, —C(CH3)2Et, —CH(CH3)cyclobutyl, —CH(Et)2, —C(CH3)2C≡CH, cyclohexyl, cyclopentyl, cyclobutyl or cyclopropyl.

### Claim 66 (depends on 65)

The intermediate of claim 65 wherein R6 is tert-butyl.

### Claim 67 (depends on 56, 57, 58, 59)

The intermediate of any one of claims 56-59 wherein RG1 is hydrogen, substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl or substituted or unsubstituted phenyl.

### Claim 68 (depends on 67)

The intermediate of claim 67 wherein RG1 is hydrogen, methyl or phenyl.

### Claim 69 (depends on 67)

The intermediate of claim 67 wherein RG1 is hydrogen.

### Claim 70 (depends on 56, 57, 58)

The intermediate of any one of claims 56-58 wherein RM1 and RM2 are each independently hydrogen, a substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl moiety; a substituted or unsubstituted phenyl moiety, or RM2 is absent when RM1 and the substitutents on L, taken together, form a substituted or unsubstituted aryl or heteroaryl moiety.

### Claim 71 (depends on 70)

The intermediate of claim 70 wherein RM1 and RM2 are each hydrogen.

### Claim 72 (depends on 56, 57, 58, 59)

The intermediate of claim 56, 57, 58 or 59 wherein g is 1 or 2

### Claim 73 (depends on 56, 57, 58)

The intermediate of any one of claims 56-58 wherein L is CRL1RL2 wherein RL1 and RL2 are each independently hydrogen, substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl or substituted or unsubstituted phenyl.

### Claim 74 (depends on 73)

The intermediate of claim 73 wherein L is CH2.
